Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

08.08.2022

5 Alzheimers Dement
1 Am J Med
1 Am J Pathol
1 BMC Geriatr
3 Brain
3 Curr Alzheimer Res
1 Dement Geriatr Cogn Disord
3 J Alzheimers Dis
2 J Am Geriatr Soc
3 J Clin Psychiatry
1 J Neurochem
3 J Neurosci
1 JAMA
1 Nat Neurosci
1 Nat Rev Neurol
1 Neurobiol Aging
1 Neurobiol Dis
2 Neurology
1 Neuropsychology
2 Neuroscience
1 PLoS One



    Alzheimers Dement

  1. LIU H, Xie Y, Wang X, Abboud MI, et al
    Exploring links between 2-oxoglutarate-dependent oxygenases and Alzheimer's disease.
    Alzheimers Dement. 2022 Jul 19. doi: 10.1002/alz.12733.
    >> Share

  2. BEYER L, Stocker H, Rujescu D, Holleczek B, et al
    Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years.
    Alzheimers Dement. 2022 Jul 19. doi: 10.1002/alz.12745.
    >> Share

  3. HANSSON O, Edelmayer RM, Boxer AL, Carrillo MC, et al
    The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease.
    Alzheimers Dement. 2022 Jul 31. doi: 10.1002/alz.12756.
    >> Share

  4. MOLONEY CM, Labuzan SA, Crook JE, Siddiqui H, et al
    Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain.
    Alzheimers Dement. 2022 Aug 3. doi: 10.1002/alz.12749.
    >> Share

  5. WANG J, Guo C, Meng Z, Zwan MD, et al
    Testing the link between isoaspartate and Alzheimer's disease etiology.
    Alzheimers Dement. 2022 Aug 4. doi: 10.1002/alz.12735.
    >> Share


    Am J Med

  6. PROKOPIDIS K, Giannos P, Ispoglou T, Witard OC, et al
    Dietary Fiber Intake is Associated with Cognitive Function in Older Adults: Data from the National Health and Nutrition Examination Survey.
    Am J Med. 2022;135:e257-e262.
    >> Share


    Am J Pathol

  7. PLASCENCIA-VILLA G, Perry G
    Neuropathological changes provide insights into key mechanisms related to Alzheimer's disease and related dementia.
    Am J Pathol. 2022 Aug 2. pii: S0002-9440(22)00206.
    >> Share


    BMC Geriatr

  8. YUAN S, Ma W, Yang R, Xu F, et al
    Sleep duration, genetic susceptibility, and Alzheimer's disease: a longitudinal UK Biobank-based study.
    BMC Geriatr. 2022;22:638.
    >> Share


    Brain

  9. GROOT C, Holstege H, Ossenkoppele R
    Do genetic factors contribute to sex-specific differences in resilience to amyloid pathology?
    Brain. 2022;145:2239-2241.
    >> Share

  10. HUSAIN M
    Molecular pathology and biomarker of progression in Alzheimer's disease.
    Brain. 2022;145:2229-2230.
    >> Share

  11. LUO J, Agboola F, Grant E, Morris JC, et al
    Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan.
    Brain. 2022 Aug 4. pii: 6655799. doi: 10.1093.
    >> Share


    Curr Alzheimer Res

  12. WU S, Zhou J, Zhang H, Barger SW, et al
    Serine racemase expression differentiates aging from Alzheimer's brain.
    Curr Alzheimer Res. 2022 Aug 5. pii: CAR-EPUB-125360.
    >> Share

  13. DE LOOZE C, Dehsarvi A, Suleyman N, Crosby L, et al
    Structural Correlates of Overt Sentence Reading in Mild Cognitive Impairment and Mild-to-Moderate Alzheimer's Disease.
    Curr Alzheimer Res. 2022 Aug 5. pii: CAR-EPUB-125362.
    >> Share

  14. JIANG F, Cheng C, Huang J, Chen Q, et al
    Mild behavioral impairment: an early sign and predictor of Alzheimer's disease dementia.
    Curr Alzheimer Res. 2022 Aug 5. pii: CAR-EPUB-125365.
    >> Share


    Dement Geriatr Cogn Disord

  15. RENFTLE D, Becker S, Brockmann K, Gasser T, et al
    Evaluation of the Dementia Apraxia Test in Parkinson's Disease Patients.
    Dement Geriatr Cogn Disord. 2022;51:271-278.
    >> Share


    J Alzheimers Dis

  16. CONTINI C, Serrao S, Manconi B, Olianas A, et al
    Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging.
    J Alzheimers Dis. 2022 Jul 26. pii: JAD220246. doi: 10.3233/JAD-220246.
    >> Share

  17. CAPRIOGLIO C, Garibotto V, Jessen F, Frolich L, et al
    The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey.
    J Alzheimers Dis. 2022 Jul 25. pii: JAD220333. doi: 10.3233/JAD-220333.
    >> Share

  18. WANG L, Davis PB, Volkow ND, Berger NA, et al
    Association of COVID-19 with New-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 29. pii: JAD220717. doi: 10.3233/JAD-220717.
    >> Share


    J Am Geriatr Soc

  19. SHAH SK, Manful A, Reich AJ, Semco RS, et al
    Advance care planning among Medicare beneficiaries with dementia undergoing surgery.
    J Am Geriatr Soc. 2021;69:2273-2281.
    >> Share

  20. LOPEZ RP, McCarthy EP, Mazor KM, Hendricksen M, et al
    ADVANCE: Methodology of a qualitative study.
    J Am Geriatr Soc. 2021;69:2132-2142.
    >> Share


    J Clin Psychiatry

  21. BURKE AD, Goldfarb D
    Facilitating Treatment Initiation in Early-Stage Alzheimer Disease.
    J Clin Psychiatry. 2022;83.
    >> Share

  22. BURKE AD, Goldfarb D
    Timely Diagnosis of Alzheimer Disease.
    J Clin Psychiatry. 2022;83.
    >> Share

  23. ANDRADE C
    Psychotropic Drugs With Long Half-Lives: Implications for Drug Discontinuation, Occasional Missed Doses, Dosing Interval, and Pregnancy Planning.
    J Clin Psychiatry. 2022;83.
    >> Share


    J Neurochem

  24. DI RISOLA D, Ricci D, Marrocco I, Giamogante F, et al
    ERp57 chaperon protein protects neuronal cells from Abeta-induced toxicity.
    J Neurochem. 2022;162:322-336.
    >> Share


    J Neurosci

  25. WALSH C, Ridler T, Margetts-Smith G, Garcia Garrido M, et al
    Beta bursting in the retrosplenial cortex is a neurophysiological correlate of environmental novelty which is disrupted in a mouse model of Alzheimer's disease.
    J Neurosci. 2022 Aug 4. pii: JNEUROSCI.0890-21.2022.
    >> Share

  26. BAIER MP, Nagaraja RY, Yarbrough HP, Owen DB, et al
    Selective Ablation of Sod2 in Astrocytes Induces Sex-Specific Effects on Cognitive Function, d-Serine Availability, and Astrogliosis.
    J Neurosci. 2022;42:5992-6006.
    >> Share

  27. CAI C, Wang L, Li S, Lou S, et al
    Ras Inhibitor Lonafarnib Rescues Structural and Functional Impairments of Synapses of Abeta1-42 Mice via alpha7nAChR-Dependent BDNF Upregulation.
    J Neurosci. 2022;42:6090-6107.
    >> Share


    JAMA

  28. SLOMSKI A
    Anti-Tau Antibody Semorinemab Fails to Slow Alzheimer Disease.
    JAMA. 2022;328:415.
    >> Share


    Nat Neurosci

  29. LIU CC, Zhao J, Fu Y, Inoue Y, et al
    Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular function.
    Nat Neurosci. 2022;25:1020-1033.
    >> Share


    Nat Rev Neurol

  30. WOOD H
    Restoring synapses in AD models.
    Nat Rev Neurol. 2022;18:453.
    >> Share


    Neurobiol Aging

  31. SLEAT DE, Maita I, Banach-Petrosky W, Larrimore KE, et al
    Elevated levels of tripeptidyl peptidase 1 do not ameliorate pathogenesis in a mouse model of Alzheimer disease.
    Neurobiol Aging. 2022;118:106-107.
    >> Share


    Neurobiol Dis

  32. MARTINEZ-DRUDIS L, Sheta R, Pellegrinato R, Loukili S, et al
    Inhibition of PLK2 activity affects APP and tau pathology and improves synaptic content in a sex-dependent manner in a 3xTg mouse model of Alzheimer's disease.
    Neurobiol Dis. 2022;172:105833.
    >> Share


    Neurology

  33. AKINCI M, Pena-Gomez C, Operto G, Fuentes-Julian S, et al
    Pre-pandemic Alzheimer Disease Biomarkers and Anxious-Depressive Symptoms During the COVID-19 Confinement in Cognitively Unimpaired Adults.
    Neurology. 2022 Aug 2. pii: WNL.0000000000200948.
    >> Share

  34. CEDRES N, Ferreira D, Nemy M, Machado A, et al
    Association of Cerebrovascular and Alzheimer Disease Biomarkers With Cholinergic White Matter Degeneration in Cognitively Unimpaired Individuals.
    Neurology. 2022 Aug 2. pii: WNL.0000000000200930.
    >> Share


    Neuropsychology

  35. GOLLAN TH, Stasenko A, Li C, Smirnov DS, et al
    Autocorrection if-->of function words in reading aloud: A novel marker of Alzheimer's risk.
    Neuropsychology. 2022 Aug 4. pii: 2022-86422-001. doi: 10.1037/neu0000829.
    of function words in reading aloud: A novel marker of Alzheimer's risk.&body=GOLLAN TH, Stasenko A, Li C, Smirnov DS, et al. Autocorrection if-->of function words in reading aloud: A novel marker of Alzheimer's risk. Neuropsychology. 2022 Aug 4. pii: 2022-86422-001. doi: 10.1037/neu0000829. https://www.ncbi.nlm.nih.gov/m/pubmed/35925735" ALT="Email" TITLE="Email"> --> >> Share


    Neuroscience

  36. PATTA PC, de Oliveira EMN, Goulart ACF, Zaluski AB, et al
    Nanoscale Structural Characterization and Impact on Long-term memory of Amyloid-beta42 Oligomeric forms in Zebrafish.
    Neuroscience. 2022;497:271-281.
    >> Share

  37. BIANCHIN MM, Snow Z
    Primary Microglia Dysfunction or Microgliopathy: A Cause of Dementias and Other Neurological or Psychiatric Disorders.
    Neuroscience. 2022;497:324-339.
    >> Share


    PLoS One

  38. TEJADA MORENO JA, Villegas Lanau A, Madrigal Zapata L, Baena Pineda AY, et al
    Mutations in SORL1 and MTHFDL1 possibly contribute to the development of Alzheimer's disease in a multigenerational Colombian Family.
    PLoS One. 2022;17:e0269955.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016